NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Organization
Innovaro, Inc. (Innovaro or the Company) commenced operations in 1997 and was originally incorporated under the laws of the State
of Florida, and subsequently under the laws of the State of Delaware in July 1999.
The Company
Innovaro is The Innovation Solutions Company focused on delivering innovation solutions to our clients through a combination of software and associated
services as well as information for strategic decision making. The Company offers a comprehensive set of software to ensure the success of any innovation project, regardless of the size or intent. The Companys unique combination of LaunchPad
software (an integrated innovation environment) and intelligence and insights services provide any business with the innovation support they need to drive success. These services are provided internationally from the Companys offices in the
United States.
Prior to March 11, 2013, the Companys stock was traded on the New York Stock Exchange (NYSE) MKT
(formerly known as the NYSE Amex) under the ticker symbol INV. On March 11, 2013, the Company was delisted from the NYSE MKT and its stock began trading on the OTCQB Marketplace under the ticker symbol INNI.
Going Concern
These consolidated
financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) including the assumption of a going concern basis which contemplates the realization of assets and
the settlement of liabilities and commitments in the normal course of business. The Company has incurred recurring losses and negative cash flows from operations. The Company incurred a net loss of $10.0 million and $4.9 million for the years
ended December 31, 2012 and 2011, respectively. In addition, the Company has a working capital deficit of $3.0 million and an accumulated deficit of $86.4 million as of December 31, 2012. These factors raise doubt about the
Companys ability to continue as a going concern.
The Companys primary cash requirements include working capital, principal and
interest payments on indebtedness, employee salaries and research and development expenditures. Its primary sources of funds are cash received from customers in connection with operations and, to a lesser extent, proceeds from the sale from time to
time of its investments and common stock.
The Company currently intends to fund its liquidity needs, including its software development
costs, with existing cash balances, cash generated from operations, collections of its existing receivable and the proceeds from sales of its investments. Given the Companys cash position, working capital deficit and expected revenues in the
near term, the Company does not expect that it will be able to fund its scheduled current debt service payments of $3.3 million (of which $3.0 million is due on May 1, 2013) and its operating requirements for the next twelve months. The Company
is in negotiations with the lender to have the principal of the note extended. The Company is exploring opportunities for obtaining a credit facility, as well as selling equity securities and certain other assets. In addition, the Company has the
capability to delay all cash intensive activities, including its software development costs, and will look to reduce costs further. However, if such measures prove inadequate, the Company could face liquidity problems and might be required to reduce
or delay planned capital expenditures and other initiatives and sell assets, and it may be unable to take any of these actions on satisfactory terms or in a timely manner. Further, any of these actions may not be sufficient to allow the Company to
service its debt obligations or may have an adverse impact on its business. The failure to generate sufficient cash from operations could have a material adverse effect on the Company.
25
The Companys future success depends on its ability to raise capital and ultimately generate revenue
and attain profitability. The Company cannot be certain that additional capital, whether through selling additional debt or equity securities or obtaining a line of credit or other loan, will be available to it or, if available, will be on terms
acceptable to the Company. If the Company issues additional securities to raise funds, these securities may have rights, preferences, or privileges senior to those of its common stock, and the Companys current shareholders may experience
dilution. If the Company is unable to obtain funds when needed or on acceptable terms, the Company may be required to curtail its current development programs, cut operating costs and forego future development and other opportunities. Without
sufficient capital to fund operations, the Company will be unable to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Principles of Consolidation
The consolidated financial statements include the accounts of Innovaro and its wholly owned subsidiaries: Innovaro Europe, Ltd. and UTEK Real Estate Holdings, Inc. and its subsidiaries: Ybor City Group,
Inc., 22nd Street of Ybor City, Inc., ABM of Tampa Bay, Inc., and Cortez 114, LLC (collectively UTEK Real Estate). All intercompany transactions and balances are eliminated in consolidation.
Reclassifications
Certain reclassifications have been made to the 2011 financial statements to conform to the 2012 financial statement presentation for discontinued
operations. The Company has reclassified the assets and liabilities of its discontinued divisions as current and non-current assets and liabilities held for sale in the consolidated balance sheets as of December 31, 2011. Additionally, the
Company has reclassified the operations of its discontinued divisions as discontinued operations in the consolidated statements of comprehensive loss for the year ended December 31, 2011. Finally, the Company has reclassified cash flows from
discontinued operations into a single line item in the consolidated statements of cash flows for the year ended December 31, 2011. Reclassifications have also been made to certain of the notes to the consolidated financial statements for
separate presentation of continuing operations and discontinued operations.
2.
|
|
Significant Accounting Policies
|
Accounts Receivable
The Company accounts for accounts receivable in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 310
Receivables
. In
accordance therewith, the allowance for doubtful accounts is deducted from the accounts receivable balance.
The Company provides an allowance
for losses on trade receivables based on a review of the current status of existing receivables and managements evaluation of periodic aging of accounts. The Company charges off accounts receivable against the allowance for losses when an
account is deemed to be uncollectible. The Company determines the allowance based on historical bad debt experience, current receivables aging, expected future write-offs, as well as an assessment of specific identifiable customer accounts
considered at risk or uncollectible. It is not the Companys policy to accrue interest on past due receivables. The expense associated with the allowance for doubtful accounts is recognized as general and administrative expense in the
consolidated statements of comprehensive loss. The allowance for doubtful accounts and notes and bad debt expense were both negligible for the years ended December 31, 2012 and 2011.
Available-for-Sale Securities
The Company classifies all investments in freely tradable equity securities as available-for-sale in accordance with FASB ASC Topic 320
Investments
Debt and Equity Securities
and our intentions regarding these instruments. Investments in equity securities of public companies continue to be accounted for using the fair value method as long as there is a market in the stock that
provides readily determinable fair values for these securities. These investments are adjusted to fair value at the end of each quarter. Unrealized gains and losses are reported in operating company equity as a component of accumulated other
comprehensive income (loss) in the consolidated balance sheets. Realized gains and losses from the sale of available-for-sale securities are determined on the first-in first-out (FIFO) method of accounting and are included as a component
of other (income) expense in the consolidated statements of comprehensive loss for the years ended December 31, 2012 and 2011.
26
Should management determine that an available-for-sale security has an other-than-temporary decline in fair
value, the Company recognizes the investment loss in the consolidated statement of comprehensive loss. Available-for-sale securities were evaluated for other-than-temporary impairment at December 31, 2012 and 2011. See Note 5 for further
discussion.
Cost Method Investments
The Company classifies its investments in equity securities of noncontrolled entities that do not have readily determinable fair values as cost method investments in accordance with FASB ASC Subtopic
325-20
Cost Method Investments
. Cost method investments are classified as non-current assets in accordance with the Companys intent and ability regarding liquidity of the investments.
Individual securities classified as cost method investments remain at cost basis unless there is a permanent impairment. The Company determines whether a
decline in fair value below the cost basis is other than temporary. If the decline in fair value is judged to be other-than-temporary, the cost basis of the individual security will be written down to fair value as a new cost basis and the amount of
the impairment will be included in earnings as a realized loss. The new cost basis cannot be adjusted upwards for subsequent recoveries in fair value. Realized gains and losses from the sale or impairment of cost method investments are determined on
the FIFO method of accounting and are included as a component of other (income) expense in the consolidated statements of comprehensive loss.
Cost method investments were considered for impairment at December 31, 2012 and 2011. At December 31, 2011, the Company determined that certain
of its cost method investments had suffered a decline in fair value below that of their respective carrying amounts and this decline was determined to be other-than-temporary. The Company recognized a loss on impairment of its cost method
investments of approximately $9,000 for the year ended December 31, 2011. There was no impairment for the year ended December 31, 2012.
Equity Method Investments
During 2010, the Company entered into a limited liability company agreement to form Verdant Ventures Advisors, LLC (Verdant Ventures). Under this agreement, the Company made an investment of
243,933 shares of the Companys common stock worth $1,000,125 in exchange for a 15% ownership in Verdant Ventures. The Company accounts for Verdant Ventures under the equity method of accounting due to the capital account structure of the
investee. Verdant Ventures operates as an independently managed technology transfer venture fund. John Micek, one of the Companys directors, is managing partner of Verdant Ventures, as well as a member of two limited liability companies that
are also parties to the limited liability company agreement of Verdant Ventures. Pursuant to the agreement, the Company is not required to make any additional capital contributions or loans to Verdant Ventures and is not involved in its management.
Verdant Ventures was eligible to sell up to one-third of the Companys contributed shares each year during a three-year period from the date the Company first contributed the shares. The Companys share of Verdant Ventures net loss
was negligible for the years ended December 31, 2012 and 2011.
The Company evaluated its investment in Verdant Ventures under FASB ASC
Topic 810
Consolidation
and concluded that this investment does not meet the requirements for consolidation. This investment has been classified as a non-current asset in the consolidated balance sheets in accordance with the Companys
intent and ability regarding liquidity of the investment.
Equity method investments were considered for impairment at December 31, 2012
and 2011. At December 31, 2011, the Company determined that this equity method investment had suffered a decline in fair value below that of its respective carrying amounts and this decline was determined to be other-than-temporary. The Company
recognized a loss on impairment of its equity method investment of approximately $209,000 for the year ended December 31, 2011, which is included as a component of other (income) expense in the consolidated statements of comprehensive loss.
There was no impairment for the year ended December 31, 2012.
Fixed Assets
Fixed assets are stated at cost less accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets of between 3 and 39.5 years.
Leasehold improvements are amortized over the shorter of the estimated useful life of the assets or the lease term. The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to the depreciation and
amortization period or the unamortized balance is warranted. See Note 7 for impairment discussion.
27
Maintenance and repairs are charged to operations when incurred. Betterments and renewals are capitalized.
When fixed assets are sold or otherwise disposed of, the asset account and related accumulated depreciation account are relieved, and any gain or loss is included as a component of other (income) expense in the consolidated statements of
comprehensive loss.
Identified Intangible Assets
The Company follows the provisions of FASB ASC Topic 360
Property, Plant and Equipment
, which establishes accounting standards for the impairment
of long-lived assets such as property, plant and equipment and intangible assets subject to amortization. The Company reviews long-lived assets to be held-and-used for impairment whenever events or changes in circumstances indicate that the carrying
amount of the assets may not be recoverable. If the sum of the undiscounted expected future cash flows over the remaining useful life of a long-lived asset group is less than its carrying amount, the asset is considered to be impaired. Impairment
losses are measured as the amount by which the carrying amount of the asset group exceeds the fair value of the asset. See Notes 7 and 8 for impairment discussion.
The Companys remaining intangible assets subject to amortization consist of, customer lists and propriety know-how that are amortized on a straight-line basis over the estimated useful lives of the
related intangible asset. The estimated useful lives of the respective intangible assets range from 5 to 6 years.
Goodwill and Intangible Assets with Indefinite Lives
Goodwill consists of the excess of cost over the fair value of net assets acquired in business combinations. Intangible assets with indefinite lives
consist principally of trade names and trademarks. The Company follows the provisions of FASB ASC Topic 350
Intangibles Goodwill and Other
, which requires an annual impairment test for goodwill and intangible assets with indefinite
lives. Goodwill is evaluated using a two-step impairment test at the reporting unit level. The first step compares the book value of a reporting unit, including goodwill, with its fair value. If the book value of a reporting unit exceeds its fair
value, the Company completes the second step in order to determine the amount of goodwill impairment loss that should be recorded. In the second step, the Company determines an implied fair value of the reporting units goodwill by allocating
the fair value of the reporting unit to all of the assets and liabilities other than goodwill. The amount of impairment is equal to the excess of the book value of goodwill over the implied fair value of that goodwill.
The Company performs the annual impairment testing of its goodwill and intangible assets using balances as of December 31, unless there are
triggering events earlier in the year. See Note 8 for impairment discussion.
Software Development Costs
FASB ASC Subtopic 985-20
Costs of Software to Be Sold, Leased or Marketed
, requires companies to expense all software development costs incurred
until technological feasibility has been established, at which time those costs are capitalized until the product is available for general release to customers. In addition, costs incurred to enhance existing software products or after the general
release of the product are required to be expensed as incurred as research and development costs.
In accordance with FASB ASC Subtopic
985-20, the Company has expensed all costs incurred to establish the technological feasibility of the Innovaro LaunchPad software (LaunchPad) as research and development costs. In addition, the Company capitalized approximately $46,000
and $225,000 in software development costs for the years ended December 31, 2012 and 2011, respectively. Capitalized software development costs are recorded as intangible assets.
The Company will amortize capitalized software costs by the greater of (a) the ratio that current gross revenues for a product bear to the total of current and anticipated future gross revenues for
that product, or (b) the straight-line method over the remaining estimated economic life of the product including the period being reported on. The Company recorded amortization expense related to software development costs of approximately
$25,000 for the year ended December 31, 2012.
The Company performs the annual impairment testing of its software development costs
recorded as intangible assets using balances as of December 31, unless there are triggering events earlier in the year. See Note 8 for impairment discussion.
28
Derivative Liability
FASB ASC Topic 815
Derivatives and Hedging
requires bifurcation of embedded derivative instruments and measurements of their fair value for accounting purposes. In addition, freestanding derivative
instruments such as certain warrants are also derivative liabilities. The Company estimates the fair value of these instruments using the Black-Scholes option pricing model. As discussed in Note 11, the Company has certain derivative warrants with a
variable exercise price. The Company considered the use of a Binomial model, but determined that the probability of the exercise price adjusting downward was remote. Derivative liabilities are recorded at fair value at inception and then are
adjusted to reflect fair value at the end of each reporting period, with any increase or decrease in the fair value being recorded in as a component of other (income) expense in the consolidated statements of comprehensive loss.
Revenue Recognition
Revenues from the sale of subscriptions to the Companys online marketplaces and online futures programs are initially deferred and subsequently recognized ratably over the term of the subscription,
which is typically one year.
The Company has certain consulting revenue that is derived from the sale of research services in intellectual
property insight, technology foresight, forecasting, scenario playing, vision, creativity and leadership, as well as the sale of services to provide for the design, development and implementation of custom software applications.
Before the Company recognizes revenue, the following criteria must be met:
|
|
|
Evidence of a financial arrangement or agreement must exist between the Company and its customer. Purchase orders, signed contracts, or electronic
confirmations are three examples of items accepted by the Company to meet this criterion.
|
|
|
|
Physical or electronic delivery of the products or services has occurred.
|
|
|
|
The price of the products or services is fixed and measurable.
|
|
|
|
Collectability of the sale is reasonably assured and receipt is probable. Collectability of a sale is determined on a customer-by-customer basis.
|
Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services
(included as a component of accounts receivable) or deferred revenue in the consolidated balance sheets. Client prepayments and retainers are classified as deferred revenue and recognized over future periods as earned.
Direct Costs of Revenue
Direct costs of revenue include salaries and related taxes, bonuses and commissions, certain outside services, business development costs, royalties and other direct project costs.
Stock-Based Compensation
At December 31, 2012, the Company had one stock-based equity plan, which is described in Note 13. The Company accounts for stock option grants in
accordance with FASB ASC Topic 718
Compensation Stock Compensation
. Stock-based compensation cost recognized during the years ended December 31, 2012 and 2011 includes compensation cost for all share-based payments based on their
respective grant date fair values estimated in accordance with Topic 718. The Company recognizes compensation expense on a straight-line basis over the requisite service period. The Company uses the Black-Scholes option pricing model to estimate
fair value of stock option grants at the grant date.
Income Taxes
Deferred taxes are provided on the asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred
tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Future tax benefits for net operating loss carryforwards are
recognized to the extent that realization of these benefits is considered more likely than not. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the
deferred tax assets will not be realized.
29
For federal and state income tax purposes, the Company is taxed at regular corporate rates on ordinary
income and recognizes gains on distributions of appreciated property.
Certain guidance located within FASB ASC Topic 740,
Income
Taxes
, clarifies the accounting for uncertainty in income taxes recognized in an enterprises financial statements. Topic 740 provides guidance on the financial statement recognition and measurement of a tax position taken or expected to be
taken in a tax return. Topic 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition. The Company had no uncertain tax positions for the years ended
December 31, 2012 and 2011.
The Company does not have any income tax benefit related to its net loss from operations in 2012 and 2011,
nor does it have a deferred tax asset related to its net operating loss carryforward, because of a 100% valuation allowance. The Company does have an income tax benefit from the reversal of a deferred tax liability related to the impairment and
amortization of certain indefinite-lived intangible assets for the years ended December 31, 2012 and 2011.
Earnings per Share (EPS)
Basic earnings per share is computed on the basis of the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed on the basis of the
weighted-average number of shares of common stock outstanding plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. The Companys dilutive potential common shares consist of
outstanding stock options, warrants and unvested shares of restricted stock.
Components of basic and diluted per share data are as follows:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2012
|
|
|
2011
|
|
Weighted average outstanding shares of common stock
|
|
|
15,464,506
|
|
|
|
15,013,299
|
|
|
|
|
Dilutive effect of stock options, warrants and unvested shares of restricted stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock and common stock equivalents
|
|
|
15,464,506
|
|
|
|
15,013,299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares excluded from calculation of diluted EPS
(1)
|
|
|
4,072,933
|
|
|
|
2,908,548
|
|
|
|
|
|
|
|
|
|
|
(1)
|
These shares attributable to outstanding stock options, warrants and unvested restricted stock were excluded from the calculation of diluted EPS
because their inclusion would have been anti-dilutive, primarily as a result of having incurred a net loss during the periods presented.
|
Financial Instruments
The Companys financial instruments consist of investments and cash, accounts receivable, accounts payable, accrued expenses, long-term debt and
derivative liability. The fair value of accounts receivable, accounts payable and certain accrued expenses approximate their carrying amounts in the financial statements due to the short maturity of such instruments. The estimated fair value of the
Companys long-term debt at December 31, 2012 and 2011 is not materially different from its carrying values of $5,233,416 and $5,642,439, respectively. The fair value of available-for-sale securities and derivative liability are determined
as described in Note 4.
Concentrations of Credit Risk
Financial instruments that the Company holds with significant credit risk include cash and investments. The Company maintains its cash with high credit quality financial institutions in the United States
and, at times, balances may exceed federally insured limits. The Company has not experienced any losses related to these balances. All of the Companys non-interest bearing cash balances were fully insured as of December 31, 2012.
30
Use of Estimates
The preparation of the Companys consolidated financial statements in conformity with FASB ASC Topic 275
Risks and Uncertainties
requires management to make estimates and assumptions that
could affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Companys
most significant estimates relate to revenue recognition, the valuation and impairment of certain investments, stock-based compensation, the valuation and impairment of goodwill and intangible assets, and the derivative liability. Actual results
could differ from those estimates.
Recently Issued Accounting Pronouncements
In May 2011, the FASB issued an accounting standards update on fair value measurements and disclosures that was the result of work completed by them and
the International Accounting Standards Board to develop common requirements for measuring fair value and for disclosing of information about fair value measurements. The additional disclosures required by the new standard include quantitative
information about the significant unobservable inputs used in Level 3 recurring and non-recurring fair value measurements, a description of the valuation processes used for recurring and non-recurring fair value measurements, and qualitative
information about the sensitivity of recurring fair value measurements to changes in unobservable inputs. The Company has adopted this accounting standards update effective January 1, 2012. Adoption of this standard had no impact on the
Companys consolidated financial statements.
In June 2011, the FASB issued an accounting standards update that eliminates the option to
present the components of other comprehensive income (loss) as part of the statement of changes in stockholders equity. Under the new standard, the components of net income (loss) and other comprehensive income (loss) can be presented in
either a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements. The Company has adopted this accounting standards update effective January 1, 2012. In accordance with this new standard, the
Company has presented a continuous statement of comprehensive loss.
In September 2011, the FASB issued an accounting standards update in
order to simplify how goodwill is tested for impairment. Prior to the issuance of this update, goodwill was required to be tested for impairment on at least an annual basis by comparing the fair value of a reporting unit with its carrying amount
including goodwill. If the fair value of the reporting unit was less than its carrying amount, then measurement of the amount of impairment was required. Under the new standard, the Company is not required to calculate the fair value of a reporting
unit unless it determines that it is more likely than not that its fair value is less than its carrying amount. The amendments in this standard are effective for interim and annual periods beginning January 1, 2012 with early adoption
permitted. The Company has adopted this accounting standards update effective January 1, 2012 and applied the guidance to its annual goodwill impairment test as of December 31, 2012. Adoption of this standard had no impact on the
Companys consolidated financial statements.
In December 2011, the FASB issued an accounting standards update to require disclosure of
information about the effect of rights of setoff with certain financial instruments on an entitys financial position. In January 2013, the FASB issued an accounting standards update that clarifies the aforementioned offsetting disclosure
requirements. The disclosure requirements are only applicable to rights of setoff of certain derivative instruments, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either
offset in accordance with standards set forth by the FASB Codification or master netting arrangements or similar agreements. The Company has adopted the amendments in these standards effective in the first quarter of 2013. Adoption of this standard
had no impact on the Companys consolidated financial statements.
In February 2013, the FASB issued an accounting standards update that
requires presentation for reclassification adjustments from accumulated other comprehensive income into net income in a single note or on the face of the financial statements. The Company has adopted the amendments in this standard effective in the
first quarter of 2013. Adoption of this standard had no impact on the Companys consolidated financial statements.
31
3.
|
|
Discontinued Operations and Divestitures
|
Pharmalicensing, Global Licensing, Pharma Transfer and Knowledge Express Operating Divisions
The Company sold its Pharmalicensing, Global Licensing, Pharma Transfer and Knowledge Express operating divisions to IP Technology Exchange, Inc.
(IP Tech Ex) effective as of August 31, 2012, pursuant to an asset purchase agreement dated September 12, 2012. Under the terms of the agreement, the Company will receive $2,000,000, consisting of (i) a lump-sum payment of
$600,000 upon closing, (ii) the assumption of approximately $70,000 of debt relating to the divisions, (iii) quarterly payments of $100,000 through August 2014, and (iv) payment of the remaining balance on September 1, 2014. On
November 30, 2012, the outstanding balance began accruing interest at 5% per annum. IP Tech Ex is entitled to a $125,000 reduction in the purchase price if all amounts are paid to the Company by May 1, 2013. See Note 19 for related
party disclosure.
In connection with the sale of these divisions, the Company recognized a loss on disposal of business of approximately
$287,000 during the year ended December 31, 2012. This loss is included as a component of income (loss) from discontinued operations in the consolidated statements of comprehensive loss. These divisions operated out of the United States and the
United Kingdom as part of the Companys Intelligence and Insights Services segment.
Strategic Services Operating Division
As part of the Companys strategy to maximize cash flow as discussed in Note 1, the Companys Board of Directors approved
the disposal of the Companys Strategos division, which operated out of its Strategic Services segment. On October 2, 2012, the Company entered into an asset purchase agreement to sell certain assets, primarily intellectual property rights
and equipment relating to our Strategos division, to one of its officers and employees for $100,000. In connection with the asset purchase agreement, the Company entered into separation and release agreements with all of the officers and employees
of our Strategos division pursuant to which they agreed to forgo approximately $1,489,000 in accrued bonuses owed them in exchange for $150,000. Finally, as part of the transaction, the Company also entered into a technology license agreement with
Strategos, Inc., a newly formed company that will carry on the business formerly conducted by our Strategos division, pursuant to which we agreed to license Strategos, Inc. certain technology and intellectual property rights relating to our
Strategos division, including the use of the name Strategos, for royalty payments equal to 12.5% of the professional fee revenue earned by Strategos, Inc. in excess of $10,000,000 during the period from October 2, 2012 to
December 31, 2015. In connection with the sale of this division, the Company recognized a gain on disposal of business of approximately $1,115,000 during the year ended December 31, 2012.
The Company has reflected the operations of these divisions as discontinued operations in the consolidated statements of comprehensive loss for all
periods presented. In addition, the Company has classified the assets and liabilities of the discontinued divisions as current and non-current assets and liabilities held for sale in the consolidated balance sheets as of December 31, 2011 for
comparability purposes. Substantially all the cash flows from discontinued operations for all periods presented relate to operating activities, and accordingly, the Company has presented cash flows from discontinued operations as a single line item
in the consolidated statements of cash flows.
The results of operations of the aforementioned divisions are included in discontinued
operations in the statements of comprehensive loss. The summary comparative financial results of discontinued operations are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2012
|
|
|
|
Strategic
Services
(1)
|
|
|
Intelligence
& Insights
(2)
|
|
|
Total
|
|
Revenue
|
|
$
|
2,557,865
|
|
|
$
|
1,199,098
|
|
|
$
|
3,756,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-lived asset impairment charge
|
|
|
4,756,898
|
|
|
|
255,126
|
|
|
|
5,012,024
|
|
Operating expense
|
|
|
2,710,352
|
|
|
|
985,132
|
|
|
|
3,695,484
|
|
Other (income) expense
|
|
|
274,258
|
|
|
|
(102,970
|
)
|
|
|
171,288
|
|
(Gain) loss on disposal of business
|
|
|
(1,114,709
|
)
|
|
|
286,819
|
|
|
|
(827,890
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(4,068,934
|
)
|
|
|
(225,009
|
)
|
|
|
(4,293,943
|
)
|
Provision for income tax (expense) benefit
|
|
|
608,800
|
|
|
|
191,703
|
|
|
|
800,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations, net of tax
|
|
$
|
(3,460,134
|
)
|
|
$
|
(33,306
|
)
|
|
$
|
(3,493,440
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
This division was sold on October 2, 2012 and the financial results reflect operations until such date.
|
(2)
|
This division was sold on August 31, 2012 and the financial results reflect operations until such date.
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2011
|
|
|
|
Strategic
Services
|
|
|
Intelligence
&
Insights
|
|
|
Total
|
|
Revenue
|
|
$
|
12,373,822
|
|
|
$
|
2,050,140
|
|
|
$
|
14,423,962
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-lived asset impairment charge
|
|
|
|
|
|
|
274,610
|
|
|
|
274,610
|
|
Operating expense
|
|
|
11,445,590
|
|
|
|
1,673,708
|
|
|
|
13,119,298
|
|
Other (income) expense
|
|
|
1,987
|
|
|
|
(57,962
|
)
|
|
|
(55,975
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
926,245
|
|
|
|
159,784
|
|
|
|
1,086,029
|
|
Provision for income tax (expense) benefit
|
|
|
96,097
|
|
|
|
|
|
|
|
96,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from discontinued operations, net of tax
|
|
$
|
1,022,342
|
|
|
$
|
159,784
|
|
|
$
|
1,182,126
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The assets and liabilities classified as held for sale as of December 31, 2011 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2011
|
|
|
|
Strategic
Services
|
|
|
Intelligence
&
Insights
|
|
|
Total
|
|
Accounts receivable, net
|
|
$
|
405,697
|
|
|
$
|
291,753
|
|
|
$
|
697,450
|
|
Contracts in progress
|
|
|
513,040
|
|
|
|
|
|
|
|
513,040
|
|
|
|
|
|
Prepaid expenses and other current assets
|
|
|
9,628
|
|
|
|
59,340
|
|
|
|
68,968
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets held for sale
|
|
$
|
928,365
|
|
|
$
|
351,093
|
|
|
$
|
1,279,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed assets, net
|
|
$
|
21,381
|
|
|
$
|
13,754
|
|
|
$
|
35,135
|
|
Goodwill
|
|
|
3,386,898
|
|
|
|
2,743,254
|
|
|
|
6,130,152
|
|
Intangible assets, net
|
|
|
1,673,125
|
|
|
|
258,686
|
|
|
|
1,931,811
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets held for sale
|
|
$
|
5,081,404
|
|
|
$
|
3,015,694
|
|
|
$
|
8,097,098
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
|
|
|
$
|
36,591
|
|
|
$
|
36,591
|
|
Accrued expenses
|
|
|
84,541
|
|
|
|
25,916
|
|
|
|
110,457
|
|
Accrued bonus
|
|
|
1,444,955
|
|
|
|
|
|
|
|
1,444,955
|
|
Deferred revenue
|
|
|
|
|
|
|
732,386
|
|
|
|
732,386
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities held for sale
|
|
$
|
1,529,496
|
|
|
$
|
794,893
|
|
|
$
|
2,324,389
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liability
|
|
$
|
608,800
|
|
|
$
|
191,703
|
|
|
$
|
800,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current liabilities held for sale
|
|
$
|
608,800
|
|
|
$
|
191,703
|
|
|
$
|
800,503
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.
|
|
Fair Value Measurements
|
The Company performs fair value measurements in accordance with the guidance provided by FASB
ASC Topic 820
Fair Value Measurements and Disclosures
. Topic 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, management considers the principal or most advantageous market in which the Company would transact and considers
assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.
Topic 820 establishes a fair value hierarchy that encourages and is based on the use of observable inputs, but allows for unobservable inputs when observable inputs do not exist. When there are multiple
inputs for determining the fair value of an investment, the Company classifies the investment in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Inputs are classified into one of three
categories:
|
|
|
Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities.
|
|
|
|
Level 2 Quoted prices in active markets for similar assets or liabilities, or quoted prices for identical or similar assets or liabilities in
markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
|
|
|
|
Level 3 Unobservable inputs for the asset or liability.
|
33
Assets measured at fair value on a recurring basis by level within the fair value hierarchy as of
December 31, 2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements
at
December 31, 2012
(1)
|
|
|
Fair Value Measurements at
December 31, 2011
(1)
|
|
|
|
Using
Level 2
|
|
|
Total
|
|
|
Using
Level 2
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities
|
|
$
|
4,765
|
|
|
$
|
4,765
|
|
|
$
|
55,038
|
|
|
$
|
55,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
4,765
|
|
|
$
|
4,765
|
|
|
$
|
55,038
|
|
|
$
|
55,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liability
|
|
$
|
29,000
|
|
|
$
|
29,000
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
29,000
|
|
|
$
|
29,000
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The Company did not have any assets or liabilities measured at fair value using Level 1 or Level 3 of the fair value hierarchy as of December 31,
2012 or 2011.
|
The Companys investments in available-for-sale securities are classified within Level 2 of the fair value hierarchy. The equity
interests in companies for which there is no liquid public market are valued using quoted market prices for identical or similar instruments in markets that are not active. The determined values are generally discounted to account for the illiquid
nature of the investment and minority ownership positions. The value of our equity interests in public companies for which market quotations are readily available are based on quoted market prices for similar instruments in an active market. These
securities are generally thinly traded and/or carry discounts from the public market value for certain restrictions on resale. The Company utilizes the market approach in determining the fair value of these securities.
The Companys derivative liability is classified within Level 2 of the fair value hierarchy. The Company utilizes the Black-Scholes Option Pricing
Model to value the derivative liability utilizing observable inputs such as the Companys common stock price, the exercise price of the warrants, and expected volatility, which is based on historical volatility. The Black-Scholes model employs
the market approach in determining fair value.
5
.
|
|
Available-for-Sale Securities
|
The Company classifies its investments in freely tradable equity securities as available-for-sale in accordance
with FASB ASC Topic 320
Investments Debt and Equity Securities
and its intentions regarding these instruments.
A summary of the estimated fair value of available-for-sale securities is as follows as of December 31, 2012 and 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized
(1)
|
|
|
Realized
Gain/Loss
|
|
|
Fair Value
|
|
|
|
Cost
|
|
|
Gain
|
|
|
Loss
|
|
|
|
|
|
|
|
|
|
As of December 31, 2012
|
|
$
|
1,827
|
|
|
$
|
|
|
|
$
|
(44,492
|
)
|
|
$
|
47,430
|
|
|
$
|
4,765
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2011
|
|
$
|
18,100
|
|
|
$
|
37,138
|
|
|
$
|
|
|
|
$
|
(200
|
)
|
|
$
|
55,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The net unrealized gain (loss) is included in operating company equity as a component of accumulated other comprehensive income (loss) in the
consolidated balance sheets.
|
Proceeds from the sale of available-for-sale securities were approximately $64,000 and $43,000 for the years ended December 31,
2012 and 2011, respectively. As of December 31, 2012, none of our four total available-for-sale securities was in an unrealized loss position. Gross realized gain (loss) as a result of the sale of available-for-sale securities was approximately
$48,000 and $19,000 for the years ended December 31, 2012 and 2011, respectively.
34
The Company had the following notes receivable at December 31, 2012 and 2011:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2012
|
|
|
2011
|
|
$1,500,000 note receivable, principal and interest as 7.00% per annum payable in full on December 31, 2012;
collateralized by a security interest in certain property located in Pasco County, Florida and certain marketable equity securities. The Company recorded $104,000 of accrued interest income on the note for each of the years ended December 31,
2012 and 2011, respectively.
(1)
|
|
$
|
780,000
|
|
|
$
|
1,804,000
|
|
|
|
|
$1,329,670 note receivable from IP Tech Ex, due in quarterly installments of principal of $100,000 through August 2014; interest
accrues at 5.00% per annum; the balance of principal and interest are payable in full on September 1, 2014; and IP Tech Ex is entitled to a $125,000 reduction in the note balance if all amounts are paid to the Company by May 1,
2013.
|
|
|
1,249,281
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total notes receivable
|
|
|
2,029,281
|
|
|
|
1,804,000
|
|
Less current maturities
|
|
|
1,199,611
|
|
|
|
1,804,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current portion
|
|
$
|
829,670
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The note was not collected on December 31, 2012 and the Company subsequently learned that, despite our related security interest, the property
located in Pasco County, Florida had been sold by the State of Florida for property taxes due. The reduction of the Companys collateral required a write-down of the note receivable to net realizable value. The Company recorded a loss of
$1,128,000 related to the write-down of this note for the year ended December 31, 2012.
|
The Company recorded impairment of approximately $900,000 to certain of its land during the year ended December 31, 2011. The
commercial real estate market for certain property had taken a significant downturn that was not expected to reverse in the near future. As a result, management determined that the decrease in the fair value of the property was other-than-temporary.
The amount of the impairment was determined based on third party valuations of the respective property. This impairment expense is included as a component of impairment loss in the consolidated statements of comprehensive loss.
Fixed assets consist of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2012
|
|
|
2011
|
|
|
|
|
Furniture and Fixtures
|
|
$
|
165,568
|
|
|
$
|
165,403
|
|
Computer Equipment
|
|
|
316,074
|
|
|
|
470,972
|
|
Leasehold Improvements
|
|
|
|
|
|
|
|
|
Building
|
|
|
1,854,357
|
|
|
|
1,854,357
|
|
Building Improvements
|
|
|
1,554,742
|
|
|
|
1,554,742
|
|
Land
|
|
|
2,635,120
|
|
|
|
2,635,120
|
|
|
|
|
|
|
|
|
|
|
Total fixed assets
|
|
|
6,525,861
|
|
|
|
6,680,594
|
|
Less: accumulated depreciation
|
|
|
(1,105,723
|
)
|
|
|
(1,082,972
|
)
|
|
|
|
|
|
|
|
|
|
Fixed assets, net
|
|
$
|
5,420,138
|
|
|
$
|
5,597,622
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense recorded as a component of continuing operations was approximately $185,000 and $216,000 for the years ended
December 31, 2012 and 2011, respectively. Depreciation expense recorded as a component of discontinued operations was approximately $9,000 and $12,000 for the years ended December 31, 2012 and 2011, respectively.
35
8.
|
|
Goodwill and Intangible Assets
|
In accordance with FASB ASC Topic 350
Intangibles Goodwill and Other
, goodwill is not subject to amortization. Goodwill
and indefinite-lived assets are reviewed for impairment by applying a fair value based test on an annual basis or more frequently if circumstances indicate impairment may have occurred. The Company assesses goodwill for impairment by comparing the
carrying values of its reporting units to their respective fair values and reviewing the Companys market value of invested capital. The Company generally determines the fair value of its reporting units primarily by comparing the reporting
unit to similar business ownership interests that have been sold. The Company also uses comparative price-to-book multiples and other factors to corroborate the reasonableness of the conclusion.
Impairment Recorded at 2011 Year-end
The Company obtained third party valuations to assist in the determination of fair value of our reporting units as of December 31, 2011. As a result
of a reduction in fair value of certain of our reporting units, management determined that the implied fair value of our goodwill and intangible assets was less than their respective carrying values. The Company recognized goodwill impairment of
$274,610, which is included in loss from discontinued operations in the consolidated statement of comprehensive loss for the year ended December 31, 2011. The Company recognized intangible asset impairment of $269,012, which is included in
impairment loss from continuing operations in the consolidated statement of comprehensive loss for the year ended December 31, 2011.
Impairment Recorded During the Second Quarter of 2012
In accordance with Topic 350, management performs interim assessments of goodwill if impairment indicators are present. At the end of the second quarter of 2012, management concluded that its revenue
projections for its Strategic Services segment needed to be revised as a result of concerns that the business may not meet its revenue and cash flow projections for the year ending December 31, 2012 due to a diminished backlog that was not
expected to turn around in the near term. This conclusion triggered a review for impairment outside of the Companys next scheduled annual impairment evaluation date of December 31, 2012. Management determined that the goodwill was
impaired and the Company recognized goodwill impairment of $3,386,898 during the second quarter of 2012, which is included in loss from discontinued operations in the consolidated statement of comprehensive loss for the year ended December 31,
2012.
In connection with the Companys decision to sell certain of its operating divisions to IP Tech Ex as discussed in Note 3, the
Company recorded goodwill impairment of $255,126 during the second quarter of 2012, which is included in loss from discontinued operations in the consolidated statement of comprehensive loss for the year ended December 31, 2012.
In addition, the Company began discussions to sell certain of its intangible assets related to its strategic services segment. Based on the terms of this
discussion, management determined that these intangible assets were impaired. The Company recognized intangible asset impairment of $1,370,000 during the second quarter of 2012, which is included in loss from discontinued operations in the
consolidated statement of comprehensive loss for the year ended December 31, 2012.
Impairment Recorded at 2012 Year-end
Due to the significant changes in the Companys business that occurred during 2012, management was not able to estimate a
price-to-book multiple for the impairment test. As such, management used the market capitalization method for its December 31, 2012 impairment analysis. Due to further reduction in the Companys market capitalization in the fourth quarter,
management determined that the implied fair value of its goodwill and intangible assets is less than their carrying values. The Company recorded intangible asset impairment of $2,052,153 during the fourth quarter of 2012, which is included in
impairment loss from continuing operations in the consolidated statement of comprehensive loss for the year ended December 31, 2012.
36
The following table presents goodwill and intangible assets as of December 31, 2012 and 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Years Ended December 31,
|
|
|
|
2012
|
|
|
2011
(
1)
|
|
|
|
Gross
Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
Carrying
Amount
|
|
|
Gross
Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
Carrying
Amount
|
|
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade names/ trademarks/ websites
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
364,020
|
|
|
$
|
291,215
|
|
|
$
|
72,805
|
|
Proprietary software/ processes/ know-how
|
|
|
320,000
|
|
|
|
213,318
|
|
|
|
106,682
|
|
|
|
2,635,172
|
|
|
|
1,425,563
|
|
|
|
1,209,609
|
|
Non-compete agreements
|
|
|
36,360
|
|
|
|
36,360
|
|
|
|
|
|
|
|
696,934
|
|
|
|
679,440
|
|
|
|
17,494
|
|
Customer list
|
|
|
250,000
|
|
|
|
139,986
|
|
|
|
110,014
|
|
|
|
2,989,804
|
|
|
|
1,511,238
|
|
|
|
1,478,566
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortizable intangible assets, net
|
|
|
|
|
|
|
|
|
|
|
216,696
|
|
|
|
|
|
|
|
|
|
|
|
2,778,474
|
|
Infinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
|
|
|
|
|
|
|
|
104,627
|
|
|
|
|
|
|
|
|
|
|
|
2,311,842
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets, net
|
|
|
|
|
|
|
|
|
|
$
|
321,323
|
|
|
|
|
|
|
|
|
|
|
$
|
5,090,316
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
$
|
6,130,152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amounts include goodwill and intangible assets that were classified as assets held for sale as of December 31, 2011.
|
The changes to the net carrying value of goodwill by continuing and discontinued operations and by business segment for the years ended
December 31, 2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing Operations
|
|
|
Discontinued
Operations
|
|
|
Total
|
|
|
|
Strategic
Services
|
|
|
Intelligence
and Insights
Services
|
|
|
|
Balance as of January 1, 2011
|
|
$
|
3,386,898
|
|
|
$
|
3,020,742
|
|
|
$
|
|
|
|
$
|
6,407,640
|
|
Transfer to discontinued operations
|
|
|
(3,386,898
|
)
|
|
|
(3,020,742
|
)
|
|
|
6,407,640
|
|
|
|
|
|
Impairment
|
|
|
|
|
|
|
|
|
|
|
(274,610
|
)
|
|
|
(274,610
|
)
|
Translation adjustment
|
|
|
|
|
|
|
|
|
|
|
(2,878
|
)
|
|
|
(2,878
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2011
(1)
|
|
|
|
|
|
|
|
|
|
|
6,130,152
|
|
|
|
6,130,152
|
|
Impairment
|
|
|
|
|
|
|
|
|
|
|
(3,642,024
|
)
|
|
|
(3,642,024
|
)
|
Translation adjustment
|
|
|
|
|
|
|
|
|
|
|
64,659
|
|
|
|
64,659
|
|
Sale of business
|
|
|
|
|
|
|
|
|
|
|
(2,552,787
|
)
|
|
|
(2,552,787
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2012
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amounts include goodwill and intangible assets that were classified as assets held for sale as of December 31, 2011.
|
37
The changes to the net carrying value of intangible assets by continuing and discontinued operations and by
business segment for the years ended December 31, 2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing Operations
|
|
|
|
|
|
|
|
|
|
Strategic
Services
|
|
|
Intelligence
and Insights
Services
|
|
|
Discontinued
Operations
|
|
|
Total
|
|
Balance as of January 1, 2011
|
|
$
|
5,004,773
|
|
|
$
|
1,170,019
|
|
|
$
|
|
|
|
$
|
6,174,792
|
|
Transfer to discontinued operations
|
|
|
(1,688,127
|
)
|
|
|
(363,252
|
)
|
|
|
2,051,379
|
|
|
|
|
|
Additions
|
|
|
225,172
|
|
|
|
|
|
|
|
|
|
|
|
225,172
|
|
Amortization
|
|
|
(805,580
|
)
|
|
|
(115,488
|
)
|
|
|
(122,453
|
)
|
|
|
(1,043,521
|
)
|
Impairment
|
|
|
|
|
|
|
(269,012
|
)
|
|
|
|
|
|
|
(269,012
|
)
|
Translation adjustment
|
|
|
|
|
|
|
|
|
|
|
2,885
|
|
|
|
2,885
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2011
(1)
|
|
|
2,736,238
|
|
|
|
422,267
|
|
|
|
1,931,811
|
|
|
|
5,090,316
|
|
Additions
|
|
|
45,524
|
|
|
|
|
|
|
|
|
|
|
|
45,524
|
|
Amortization
|
|
|
(729,609
|
)
|
|
|
(100,944
|
)
|
|
|
(70,475
|
)
|
|
|
(901,028
|
)
|
Impairment
|
|
|
(2,052,153
|
)
|
|
|
|
|
|
|
(1,370,000
|
)
|
|
|
(3,422,153
|
)
|
Translation adjustment
|
|
|
|
|
|
|
|
|
|
|
10,492
|
|
|
|
10,492
|
|
Sale of business
|
|
|
|
|
|
|
|
|
|
|
(501,828
|
)
|
|
|
(501,828
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2012
|
|
$
|
|
|
|
$
|
321,323
|
|
|
$
|
|
|
|
$
|
321,323
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amounts include goodwill and intangible assets that were classified as assets held for sale as of December 31, 2011.
|
Finite-lived intangible assets are being amortized over the estimated useful lives of the respective assets, which range between three
and ten years. Amortization expense related to intangible assets recorded as a component of continuing operations was approximately $831,000 and $921,000 for the years ended December 31, 2012 and 2011, respectively. Amortization expense related
to intangible assets recorded as a component of discontinued operations was approximately $70,000 and $122,000 for the years ended December 31, 2012 and 2011, respectively.
The estimated aggregate future amortization expense related to the Companys intangible assets with finite lives is as follows:
|
|
|
|
|
For the years ending December 31,
|
|
|
|
|
2013
|
|
$
|
100,944
|
|
2014
|
|
|
85,730
|
|
2015
|
|
|
30,022
|
|
|
|
|
|
|
Total
|
|
$
|
216,696
|
|
|
|
|
|
|
Accrued expenses are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2012
|
|
|
2011
|
|
Accrued salaries and related expenses
|
|
$
|
178,030
|
|
|
$
|
120,744
|
|
Property taxes payable
|
|
|
163,279
|
|
|
|
78,058
|
|
Board of Director fees payable
|
|
|
49,500
|
|
|
|
41,250
|
|
Accrued interest
|
|
|
43,265
|
|
|
|
44,322
|
|
Other
|
|
|
16,197
|
|
|
|
80,517
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
450,271
|
|
|
$
|
364,891
|
|
|
|
|
|
|
|
|
|
|
38
The Company had the following long-term debt at December 31, 2012 and 2011:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2012
|
|
|
2011
|
|
$3,000,000 bank note payable, due in monthly installments of $20,436 including principal and interest at 6.50% through
April 1, 2013 with a balloon payment due on May 1, 2013; collateralized by the Companys corporate office building and related land.
(
2)
|
|
$
|
2,747,768
|
|
|
$
|
2,809,199
|
|
|
|
|
$1,500,000 note payable, due in monthly installments of interest at 7.00% with principal due in full on October 1, 2015;
collateralized by the Companys corporate office building and undeveloped land in Hillsborough County, Florida.
|
|
|
1,250,000
|
|
|
|
1,250,000
|
|
|
|
|
$1,750,000 note payable, originally due on October 22, 2012; due in quarterly installments of interest in arrears at 8.00%;
amended to extend the date of the note; principal payments of $250,000 due on October 22, 2013 and $750,000 on October 22, 2015; collateralized by a security interest in 68% of one of the Companys subsidiaries, which owns undeveloped
land in Hernando County, Florida.
(1)
|
|
|
1,000,000
|
|
|
|
1,250,000
|
|
|
|
|
Discount on $1,750,000 note payable and $250,000 note payable.
|
|
|
(106,652
|
)
|
|
|
(106,798
|
)
|
|
|
|
$600,000 note payable, bank, due in monthly installments of $14,420 including principal and interest at 7.09% through November
2012.
|
|
|
|
|
|
|
155,965
|
|
|
|
|
$200,000 secured loan agreement and promissory note, originally due in full by February 15, 2012 including interest at 6.00%
and $26,000 in related fees. This note was extended in February 2012 to July 2012.
|
|
|
|
|
|
|
200,000
|
|
|
|
|
$250,000 secured loan agreement and promissory note, originally due in full by February 16, 2013 including interest at
15.00%. We are in negotiations to extend the due date of this loan.
|
|
|
250,000
|
|
|
|
|
|
|
|
|
Insurance financing, due in monthly installments of up to $12,448 and $13,603 including principal and interest at 4.20% and 5.32%
through August 2013 and September 2012, respectively.
|
|
|
92,300
|
|
|
|
84,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
|
5,233,416
|
|
|
|
5,642,439
|
|
Less current maturities
|
|
|
3,294,896
|
|
|
|
1,644,664
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current portion
|
|
$
|
1,938,520
|
|
|
$
|
3,997,775
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The lender agreed to extend the maturity date of the promissory note for which the outstanding balance of $1,250,000 million would otherwise have been
due on October 22, 2012 under a second amendment to the promissory note. In accordance with the terms of the amendment, the maturity date of the promissory note has been extended from October 22, 2012 to October 22, 2015. The Company
repaid $250,000 of the $1,250,000 due under the promissory note on December 3, 2012 and agreed to repay an additional $250,000 on or before October 22, 2013 and the final $750,000 on or before October 22, 2015. The interest rate
payable on amounts outstanding under the promissory note remained unchanged at 8.0% per year and there is no penalty if we pre-pay all or a portion of the promissory note prior to the scheduled repayments dates set forth above. As an inducement
for the lender to extend the due date of the note, the Company issued certain warrants to the lender. See the Stock Warrants section of Note 12 for further discussion of these warrants.
|
(2)
|
The Company is in negotiations with the lender to have the principal of the note extended.
|
39
Payments required for the next five years on the long-term debt balance as of December 31, 2012 are as
follows:
|
|
|
|
|
For the years ending December 31,
|
|
|
|
|
2013
|
|
$
|
3,294,896
|
|
2014
|
|
|
|
|
2015
|
|
|
1,938,520
|
|
|
|
|
|
|
Total
|
|
$
|
5,233,416
|
|
|
|
|
|
|
11.
|
|
Derivative Liabilities
|
In accordance with FASB ASC Topic 815
Derivatives and Hedging
, the Company has recorded derivative liabilities for certain stock
warrants with variable exercise prices. See the Stock Warrants section of Note 12 for further discussion of these warrants. Derivative liabilities are recorded at fair value at inception and then are adjusted to reflect fair value at the end of each
reporting period, with any increase or decrease in the fair value being recorded as a component of other (income) expense in the consolidated statements of comprehensive loss. The Company recognized a gain (loss) related to the adjustment of these
derivatives to fair value of approximately $51,000 and $(151,000) for the years ended December 31, 2012 and 2011, respectively.
The
Company uses the Black-Scholes option pricing model to estimate the fair value of the derivative instrument. The Company employed the following weighted-average assumptions for the Black-Scholes model at December 31, 2012:
|
|
|
|
|
Expected dividend yield
|
|
|
0
|
%
|
Expected volatility
|
|
|
72
|
%
|
Risk-free interest rate
|
|
|
0.72
|
%
|
Expected life of options
|
|
|
5.0 years
|
|
Fair value per share
|
|
$
|
0.095
|
|
Warrant Exercise
Effective April 6, 2011, 437,500 of the Companys $0.01 fully vested common stock warrants were exercised. The derivative liability related to
the warrants was adjusted to fair value of approximately $1.3 million on the date of exercise and effectively extinguished through an adjustment to additional paid-in capital.
Accumulated Other Comprehensive Income
Components comprising the balance in accumulated other comprehensive income for the years ended December 31, 2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized
gain (loss)
from
available-for-
sale
securities
|
|
|
Foreign
currency
translation
adjustment
|
|
|
Accumulated
other
comprehensive
income
|
|
Balance at January 1, 2011
|
|
$
|
129,040
|
|
|
$
|
18,882
|
|
|
$
|
147,922
|
|
Gain (loss) for the year
|
|
|
(91,901
|
)
|
|
|
(2,082
|
)
|
|
|
(93,983
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2011
|
|
|
37,139
|
|
|
|
16,800
|
|
|
|
53,939
|
|
Gain (loss) for the year
|
|
|
(34,000
|
)
(1)
|
|
|
74,017
|
(2)
|
|
|
40,017
|
|
Reclassification into accumulated deficit in connection with disposal of business
|
|
|
|
|
|
|
(90,817
|
)
|
|
|
(90,817
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2012
|
|
$
|
3,139
|
|
|
$
|
|
|
|
$
|
3,139
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Other comprehensive loss for the year ended December 31, 2012 per the consolidated statement of comprehensive loss agrees to the gain (loss)
for the period related to the unrealized gain (loss) from available-for-sale securities.
|
(2)
|
The gain (loss) for the period related to the foreign currency translation adjustment is included in discontinued operations for the year ended
December 31, 2012.
|
40
Securities Offering
On June 20, 2012, the Company entered into a securities purchase agreement with Messrs. Mark Berset and Bruce Lucas, each a member of the Companys Board of Directors at the time, pursuant to
which the Company agreed to issue them, in a registered offering, 271,740 shares of the Companys common stock priced at $0.92 per share along with Series A warrants to purchase up to 135,870 shares of common stock with an exercise price of
$1.16 per share. The Series A warrants are exercisable for a three-year period commencing on the date of their issuance. If the average closing price of the shares is greater than or equal to $1.16 for any 20 consecutive trading day period after the
date the Series A warrants are issued, then the Company may force the holders of the Series A warrants to exercise their warrants. The Company completed the offering and raised gross proceeds of $250,000 before offering expenses. These securities
were offered pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission (SEC).
On September 27, 2012, the Company entered into a securities purchase agreement with JJJ Family LLLP pursuant to which the Company agreed to issue, in a registered offering, 531,915 shares of its
common stock priced at $0.47 per share along with Series B warrants to purchase up to 531,915 shares of common stock with an exercise price of $0.47 per share of common stock. The Series B warrants will be exercisable for a five-year period
commencing on the six month anniversary of the date of its issuance. The securities purchase agreement provides the buyer with the right to participate in future offerings of the Companys securities, in an amount up to $250,000 in each
offering, for a period of one year after the date of the sale. These securities were offered pursuant to a registration statement previously filed and declared effective by the SEC. The Company completed the offering and raised gross proceeds of
$250,000 before offering expenses.
Other Common Stock Issuances
During the year ended December 31, 2012, the Company issued 282,753 shares of common stock with a value of $182,250 to members of its Board of Directors and certain others in lieu of payment for
services rendered.
Stock Warrants
Effective April 6, 2011, 437,500 of the Companys $0.01 fully vested common stock warrants were exercised. The Company issued 436,013 shares of common stock in the cashless exercise of these
warrants.
Effective October 22, 2012, the Company issued Series B warrants to one of the Companys Lenders. The Lender received
(i) warrants to purchase up to 150,000 shares of the Companys common stock with an exercise price of $0.66 per share; (ii) warrants to purchase up to 75,000 shares of the Companys common stock with an exercise price of $0.66
per share if and only if the Companys indebtedness under the Promissory Note has not been repaid in full by October 22, 2013 and (iii) warrants to purchase up to an additional 75,000 shares of the Companys common stock with an
exercise price of $0.66 per share if and only if the Companys indebtedness under the Promissory Note has not been repaid in full by October 22, 2014. The warrants become exercisable on April 23, 2013 and expire on October 22,
2017.
The Company also has Series A warrants issued in July 2010, to purchase 1,481,481 shares of its common stock outstanding as of
December 31, 2012. These warrants are fully vested and have an exercise price of $3.49 per share. The warrants expire in January 2016.
13.
|
|
Stock-Based Compensation Plans
|
In June 2011, the Companys stockholders approved an amendment and restatement of the Companys three existing equity
compensation plans as one plan, the Innovaro, Inc. Equity Compensation Plan (the Equity Compensation Plan). The maximum number of shares available for issuance under the Equity Compensation Plan was 4,626,274, which was the total number
of shares available under the then existing Non-Qualified Option Plan, Employee Option Plan and Restricted Stock Plan. The options and restricted stock previously granted under the three then existing equity compensation plans are counted in
determining the shares that remain available for issuance under the Equity Compensation Plan. The Compensation Committee of the Companys Board of Directors determines those officers, employees, directors and consultants of the Company who are
eligible to participate in the Equity Compensation Plan.
41
The options can be granted as incentive stock options within the meaning of Section 422 of the Internal
Revenue Code (the Code) or as options that do not qualify for incentive treatment under Section 422 of the Code. Options are granted at the fair market value of the stock on the date of grant, except in the case of a more than 10%
shareholder for which grants are exercisable at 110% of fair market value of the stock on the date of grant. Options generally become fully vested three to four years from the date of grant and expire five to seven years from the date of grant. At
December 31, 2012, the Company had 2,402,820 shares available for future stock or option grants under the Equity Compensation Plan.
Stock-based compensation cost recognized during the years ended December 31, 2012 and 2011 includes compensation cost for all grants of stock
options and restricted stock based on their respective grant date fair values estimated in accordance with FASB ASC Topic 718
Compensation Stock Compensation
. The Company recognizes compensation expense on a straight-line basis over
the requisite service period. The Company estimates forfeitures, both at the grant date as well as throughout the requisite service period, based on the Companys historical experience and future expectations.
Topic 718 requires management to estimate, at the grant date, the number of stock
options for which the requisite service is expected to be rendered. The Company applies a forfeiture rate to account for the number of stock options for which the requisite service period is not expected to be rendered. Management revised its
estimate of the forfeiture rate of its options in 2009 and 2010 to account for significant variances between the estimated forfeitures and the actual forfeitures. The revision to the forfeiture rate is accounted for as a change in estimate in
accordance with FASB ASC Topic 250
Accounting Changes and Error Corrections
and the cumulative effect of approximately $178,000, a reduction in stock-based compensation, was recognized for the year ended December 31, 2011. In addition,
the revision to the forfeiture rate caused an additional reduction in stock-based compensation of approximately $300,000 and $481,000 for the years ended December 31, 2012 and 2011, respectively. The change in estimate resulted in a beneficial
effect of $0.02 and $0.03 per share on the Companys net loss per share for the years ended December 31, 2012 and 2011, respectively. In connection with these revisions, stock-based compensation for prospective periods will be reduced by
approximately $47,000 over the next year.
The Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The
assumptions employed in the calculation of the fair value of share-based compensation expense were calculated as follows for all years presented:
|
|
|
Expected dividend yield based on the Companys historical dividend yield.
|
|
|
|
Expected volatility based on the Companys historical market price at consistent points in a period equal to the expected life of the
options.
|
|
|
|
Risk-free interest rate based on the US Treasury yield curve in effect at the time of grant.
|
|
|
|
Expected life of options based on the Companys historical life of options exercised, giving consideration to the contractual terms of the
grants, vesting schedules and expectations of future employee behavior.
|
The following table summarizes the assumptions used
to estimate the fair value of stock options granted during the years ended December 31, 2012 and 2011:
|
|
|
|
|
|
|
|
|
For the Years Ended
December 31,
|
|
|
2012
|
|
|
2011
|
Expected dividend yield
|
|
|
0
|
%
|
|
0%
|
Expected volatility
|
|
|
78
|
%
|
|
53-66%
|
Risk-free interest rate
|
|
|
0.33
|
%
|
|
0.74-1.14%
|
Expected life of options
|
|
|
4.0 years
|
|
|
4.0 years
|
Weighted-average grant date fair value
|
|
$
|
0.23
|
|
|
$1.02
|
The Company did not have any cash proceeds from the exercise of stock options for the years ended December 31, 2012 and 2011.
Total compensation cost related to stock options that was recorded as a component of continuing operations was approximately $192,000 and $293,000 for the years ended December 31, 2012 and 2011, respectively. Total compensation cost related to
stock options recorded as a component of discontinued operations was approximately $131,000 and $216,000 for the years ended December 31, 2012 and 2011, respectively. At December 31, 2012, there was approximately $265,000 of unrecognized
compensation cost related to stock options, which is expected to be recognized over a weighted average period of 2.5 years.
42
The following table represents stock option activity as of and for the two years ended December 31,
2012:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Life
|
|
|
Aggregate
Intrinsic
Value
|
|
Options Outstanding January 1, 2011
|
|
|
1,270,167
|
|
|
$
|
4.45
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
677,250
|
|
|
$
|
2.19
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited/cancelled/expired
|
|
|
(640,350
|
)
|
|
$
|
4.91
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding December 31, 2011
|
|
|
1,307,067
|
|
|
$
|
3.05
|
|
|
|
5.6 years
|
|
|
$
|
35,150
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
840,000
|
|
|
$
|
0.37
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited/cancelled/expired
|
|
|
(538,400
|
)
|
|
$
|
3.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding December 31, 2012
|
|
|
1,608,667
|
|
|
$
|
1.47
|
|
|
|
5.9 years
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Exercisable December 31, 2012
|
|
|
818,417
|
|
|
$
|
1.74
|
|
|
|
5.8 years
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total grant date fair value of options vested during the years ended December 31, 2012 and 2011 was approximately $264,000 and
$423,000, respectively.
The following table summarizes information about outstanding and exercisable stock options as of December 31,
2012:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding Options
|
|
|
Exercisable Options
|
|
Range of Exercise Prices
|
|
Outstanding
at 12/31/12
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Remaining
Contractual
Life in
Years
|
|
|
Exercisable
at 12/31/12
|
|
|
Weighted
Average
Exercise
Price
|
|
$0.275 $0.77
|
|
|
880,000
|
|
|
$
|
0.39
|
|
|
|
6.9
|
|
|
|
417,500
|
|
|
$
|
0.35
|
|
$1.16 $2.40
|
|
|
568,667
|
|
|
$
|
2.08
|
|
|
|
5.2
|
|
|
|
270,917
|
|
|
$
|
2.14
|
|
$4.00 $9.30
|
|
|
160,000
|
|
|
$
|
5.26
|
|
|
|
3.5
|
|
|
|
130,000
|
|
|
$
|
5.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,608,667
|
|
|
$
|
1.47
|
|
|
|
5.9
|
|
|
|
818,417
|
|
|
$
|
1.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table represents restricted stock activity as of and for the two years ended December 31, 2012:
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
|
Weighted-
average
Grant Date
Fair Value
|
|
Restricted Stock Outstanding January 1, 2011
|
|
|
|
|
|
|
|
|
Granted
|
|
|
145,000
|
|
|
$
|
1.19
|
|
Vested and stock issued
|
|
|
(20,000
|
)
|
|
$
|
0.77
|
|
Forfeited
|
|
|
(5,000
|
)
|
|
$
|
0.77
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Outstanding December 31, 2011
|
|
|
120,000
|
|
|
$
|
1.28
|
|
Granted
|
|
|
15,000
|
|
|
$
|
0.67
|
|
Vested and stock issued
|
|
|
(40,000
|
)
|
|
$
|
1.39
|
|
Forfeited
|
|
|
(80,000
|
)
|
|
$
|
1.22
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Outstanding December 31, 2012
|
|
|
15,000
|
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
43
14.
|
|
Other (Income) Expense
|
Components comprising the balance in other (income) expense from continuing operations for the years ended December 31, 2012 and
2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2012
|
|
|
2011
|
|
Loss (gain) on sale and impairment on investments
|
|
$
|
(47,630
|
)
|
|
$
|
(18,670
|
)
|
Dividend income
|
|
|
(315,000
|
)
|
|
|
|
|
Loss (gain) on derivative liabilities
|
|
|
(51,000
|
)
|
|
|
150,825
|
|
Rental income
|
|
|
(376,819
|
)
|
|
|
(317,097
|
)
|
Other
|
|
|
(61,349
|
)
|
|
|
128,086
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense
|
|
$
|
(851,798
|
)
|
|
$
|
(56,856
|
)
|
|
|
|
|
|
|
|
|
|
Deferred income tax assets and liabilities are determined based upon differences between financial reporting and the tax basis of
assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
The components of the income tax provision on operations, excluding income tax expense (benefit) on realized gains (losses) and unrealized appreciation (depreciation) of investments for
2012 and 2011 are as follows:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2012
|
|
|
2011
|
|
Current:
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
|
|
|
$
|
|
|
State
|
|
|
|
|
|
|
|
|
Foreign
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
(647,386
|
)
|
|
$
|
(163,017
|
)
|
State
|
|
|
(69,118
|
)
|
|
|
(17,404
|
)
|
Foreign
|
|
|
(235,230
|
)
|
|
|
(49,722
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(951,734
|
)
|
|
|
(230,143
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
$
|
(951,734
|
)
|
|
$
|
(230,143
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes, discontinued operations
|
|
$
|
(800,503
|
)
|
|
$
|
(96,097
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes, continuing operations
|
|
$
|
(151,231
|
)
|
|
$
|
(134,046
|
)
|
|
|
|
|
|
|
|
|
|
44
A reconciliation of the differences between the effective income tax rate and the statutory federal tax rate
follows:
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2012
|
|
|
2011
|
|
|
|
|
Tax at US statutory rate
|
|
$
|
(3,621,145
|
)
|
|
$
|
(1,764,521
|
)
|
State taxes, net of federal benefit
|
|
|
(386,610
|
)
|
|
|
(188,389
|
)
|
Foreign rate differential
|
|
|
(98,840
|
)
|
|
|
11,456
|
|
Stock options
|
|
|
104,939
|
|
|
|
126,905
|
|
Gain/loss on derivative liabilities
|
|
|
(19,191
|
)
|
|
|
(302,263
|
)
|
Impairment and amortization of intangible assets
|
|
|
1,805,972
|
|
|
|
|
|
|
|
|
Other items
|
|
|
618,504
|
|
|
|
55,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,596,371
|
)
|
|
|
(2,061,341
|
)
|
|
|
|
Change in valuation allowance
|
|
|
644,637
|
|
|
|
1,831,198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
$
|
(951,734
|
)
|
|
$
|
(230,143
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes, discontinued operations
|
|
$
|
(800,503
|
)
|
|
$
|
(96,097
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes, continuing operations
|
|
$
|
(151,231
|
)
|
|
$
|
(134,046
|
)
|
|
|
|
|
|
|
|
|
|
Significant components of the Companys deferred tax assets and liabilities are as follows:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2012
|
|
|
2011
|
|
Deferred tax assets
|
|
|
|
|
|
|
|
|
Net operating loss carryforward
|
|
$
|
11,658,628
|
|
|
$
|
11,861,250
|
|
Capital loss carryforward
|
|
|
6,982,469
|
|
|
|
7,085,790
|
|
Investments
|
|
|
2,602,310
|
|
|
|
2,660,439
|
|
Accrued expenses
|
|
|
56,383
|
|
|
|
534,451
|
|
Other
|
|
|
1,599,734
|
|
|
|
976,059
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
|
22,899,524
|
|
|
|
23,117,989
|
|
Valuation allowance
|
|
|
(22,816,613
|
)
|
|
|
(22,171,976
|
)
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets, net of valuation allowance
|
|
|
82,911
|
|
|
|
946,013
|
|
Deferred tax liabilities
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
|
(120,913
|
)
|
|
|
(1,808,553
|
)
|
Revenue recognition
|
|
|
|
|
|
|
(128,002
|
)
|
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
|
(120,913
|
)
|
|
|
(1,936,555
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability
|
|
$
|
(38,002
|
)
|
|
$
|
(990,542
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability related to discontinued operations
|
|
$
|
|
|
|
|
(800,503
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability related to continuing operations
|
|
$
|
(38,002
|
)
|
|
$
|
(190,039
|
)
|
|
|
|
|
|
|
|
|
|
The Company is currently subject to examination by federal and state taxing authorities for 2009 and subsequent years.
FASB ASC Topic 740
Income Taxes
requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence,
it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Companys management previously determined that it was more likely than not that the Companys net operating loss and capital loss
carryforwards would not be utilized in the future. Accordingly, a valuation allowance of $22.8 million and $22.2 million was recorded for 2012 and 2011, respectively.
45
The Company has the following U.S. net operating loss carryforwards available as of December 31, 2012:
|
|
|
|
|
Expiration Date
|
|
Amount
|
|
2021
|
|
$
|
753,000
|
|
2022
|
|
|
371,000
|
|
2023
|
|
|
1,645,000
|
|
2024
|
|
|
69,000
|
|
2025
|
|
|
3,835,000
|
|
2026
|
|
|
0
|
|
2027
|
|
|
5,076,000
|
|
2028
|
|
|
5,397,000
|
|
2029
|
|
|
7,343,000
|
|
2030
|
|
|
3,706,000
|
|
2031
|
|
|
565,000
|
|
2032
|
|
|
1,457,000
|
|
|
|
|
|
|
|
|
$
|
30,217,000
|
|
|
|
|
|
|
The Company has the following U.S. capital loss carryforwards available as of December 31, 2012:
|
|
|
|
|
Expiration Date
|
|
Amount
|
|
2013
|
|
$
|
860,000
|
|
2014
|
|
|
16,669,000
|
|
2015
|
|
|
843,000
|
|
2016
|
|
|
77,000
|
|
2017
|
|
|
107,000
|
|
|
|
|
|
|
|
|
$
|
18,556,000
|
|
|
|
|
|
|
FASB ASC Topic 280
Segment Reporting
establishes standards for reporting information about
operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to
allocate resources and in assessing performance. The Company is organized geographically and by line of business. The line of business management structure is the primary basis for which the allocation of resources and financial results are
assessed.
The Company sold the Pharmalicensing, Global Licensing, Pharma Transfer and Knowledge Express operating divisions during the third
quarter of 2012. These divisions operated out of the United States and the United Kingdom as part of the Intelligence and Insights Services segment. In addition, the Company sold its Strategos division, which operated out of the United States as
part of the Strategic Services segment, during the fourth quarter of 2012. See Note 3 for further discussion of the sale of these divisions. The Company has reflected the operations of the operations of these divisions as discontinued operations for
all periods presented. As a result, revenue and loss from continuing operations before income taxes shown below do not include amounts related to these divisions.
46
A summary of revenue and other financial information by reportable geographic operating segment is shown
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United
Kingdom
|
|
|
United States
|
|
|
Discontinued
Operations
|
|
|
Total
|
|
Long-lived assets as of December 31, 2012
|
|
$
|
|
|
|
$
|
5,741,461
|
|
|
$
|
|
|
|
$
|
5,741,461
|
|
Total assets as of December 31, 2012
|
|
|
|
|
|
|
8,469,342
|
|
|
|
|
|
|
|
8,469,342
|
|
Long-lived assets as of December 31, 2011
|
|
|
|
|
|
|
8,756,127
|
|
|
|
8,097,098
|
|
|
|
16,853,225
|
|
Total assets as of December 31, 2011
|
|
|
4,633
|
|
|
|
11,398,410
|
|
|
|
9,363,222
|
|
|
|
20,766,265
|
|
A summary of revenue and other financial information by reportable line of business segment is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2012
|
|
|
|
Strategic
Services
|
|
|
Intelligence
&
Insights
Services
|
|
|
Administrative
and Other
|
|
|
Total
|
|
Revenue
|
|
$
|
|
|
|
$
|
530,834
|
|
|
$
|
|
|
|
$
|
530,834
|
|
Loss from continuing operations before income taxes
|
|
|
|
|
|
|
(209,152
|
)
|
|
|
(6,448,238
|
)
|
|
|
(6,657,390
|
)
|
Loss from discontinued operations, net of tax
|
|
|
(3,460,134
|
)
|
|
|
(33,306
|
)
|
|
|
|
|
|
|
(3,493,440
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2011
|
|
|
|
Strategic
Services
|
|
|
Intelligence
&
Insights
Services
|
|
|
Administrative
and Other
|
|
|
Total
|
|
Revenue
|
|
$
|
|
|
|
$
|
435,425
|
|
|
$
|
|
|
|
$
|
435,425
|
|
Loss from continuing operations before income taxes
|
|
|
|
|
|
|
(529,225
|
)
|
|
|
(5,707,670
|
)
|
|
|
(6,236,895
|
)
|
Income from discontinued operations, net of tax
|
|
|
1,022,342
|
|
|
|
159,784
|
|
|
|
|
|
|
|
1,182,126
|
|
17.
|
|
Employee Benefit Plan
|
On February 1, 2009, the Company adopted the UTEK Corporation 401k Plan (the 401k Plan). The 401k Plan allows
employees who satisfy the service requirements of the 401k Plan, which include being 21 years of age and having three months of service, to contribute pre-tax wages to the 401k Plan, subject to legal limits. The Companys contributions, which
vest immediately, match 100% of the first 3%, and 50% of the second 2%, of compensation contributed by employees. Total 401k Plan expense that was recorded as a component of continuing operations was approximately $16,000 and $22,000 for the years
ended December 31, 2012 and 2011, respectively. Total 401k Plan expense recorded as a component of discontinued operations was approximately $45,000 and $86,000 for the years ended December 31, 2012 and 2011, respectively. The 401k Plan
was terminated at the end of 2012.
47
18.
|
|
Commitments and Contingencies
|
Operating Leases
The Company leases its office facilities and certain equipment for various terms under long-term, non-cancelable operating lease agreements. The leases
expire at various dates through 2013 and provide for various renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties. The leases provide for increases in future
minimum annual rental payments. Lease expense recorded as component of continuing operations was approximately $104,000 and $46,000 for the years ended December 31, 2012 and 2011, respectively. Lease expense recorded as component of
discontinued operations was approximately $94,000 and $130,000 for the years ended December 31, 2012 and 2011, respectively.
The
following is a schedule by year of future minimum rental payments required under the operating lease agreements:
|
|
|
|
|
For the years ending December 31,
|
|
|
|
|
2013
|
|
$
|
65,620
|
|
2014
|
|
|
43,146
|
|
|
|
|
|
|
|
|
$
|
108,766
|
|
|
|
|
|
|
19.
|
|
Related Party Transactions
|
During the year ended December 31, 2012, the company sold three of its operating divisions to IP Tech Ex for $2,000,000. See
Note 3 for further discussion of this transaction. Ms. Wright, the Companys Chief Financial Officer, directly owns a 7% interest in IP Tech Ex. Mr. Reiber, the Companys general counsel, indirectly owns a 7% ownership
position. Neither party holds a seat on the Companys Board of Directors, nor do they have a role in managing the Company. The price established by the Companys Board of Directors for the three divisions was based on a separate letter of
intent previously submitted to the Company for the same three divisions. The Company has a note receivable from IP Tech Ex for the remaining unpaid balance of $1,249,281 including accrued interest at 5% per annum.
48